It has been shown that cancer cells activate the PERK-eIF2α-ATF4 axis to mediate hypoxia tolerance [14], translation of angiogenic factors [48], upregulation of autophagy genes [49], and crosstalk with the HIF pathway [50,51]. The gene discussed is EIF2A; the disease is cancer.